Interventional Cardiology Publications

Author Correction: The contribution of amyloid deposition in the aortic valve to calcification and aortic stenosis.

Sud K, Narula N, Aikawa E, Arbustini E, Pibarot P, Merlini G, Rosenson RS, Seshan SV, Argulian E, Ahmadi A, Zhou F, Moreira AL, Côté N, Tsimikas S, Fuster V, Gandy S, Bonow RO, Gursky O, Narula J.Nat Rev Cardiol. 2023 Jun;20(6):429. doi: 10.1038/s41569-023-00848-4 PMID: 36807395

The contribution of amyloid deposition in the aortic valve to calcification and aortic stenosis.

Toll-Like Receptor 3 Mediates Aortic Stenosis Through a Conserved Mechanism of Calcification.

Gollmann-Tepeköylü C, Graber M, Hirsch J, Mair S, Naschberger A, Pölzl L, Nägele F, Kirchmair E, Degenhart G, Demetz E, Hilbe R, Chen HY, Engert JC, Böhm A, Franz N, Lobenwein D, Lener D, Fuchs C, Weihs A, Töchterle S, Vogel GF, Schweiger V, Eder J, Pietschmann P, Seifert M, Kronenberg F, Coassin S, Blumer M, Hackl H, Meyer D, Feuchtner G, Kirchmair R, Troppmair J, Krane M, Weiss G, Tsimikas S, Thanassoulis G, Grimm M, Rupp B, Huber LA, Zhang SY, Casanova JL, Tancevski I, Holfeld J.Circulation. 2023 May 16;147(20):1518-1533. doi: 10.1161/CIRCULATIONAHA.122.063481 Epub 2023 Apr 4.PMID: 37013819

Interaction of COVID-19 With Common Cardiovascular Disorders.

Boulos PK, Freeman SV, Henry TD, Mahmud E, Messenger JC.Circ Res. 2023 May 12;132(10):1259-1271. doi: 10.1161/CIRCRESAHA.122.321952. Epub 2023 May 11.PMID: 37167359

Percutaneous Suture - Closure Device Used for Iatrogenic Carotid Artery Injury Management: Case Report and Review of Literature.

Hu Y, Al Khiami B.Vasc Endovascular Surg. 2023 May;57(4):414-416. doi: 10.1177/15385744231151557. Epub 2023 Jan 8.PMID: 36617851

Time to Standardize Definitions for the Success and Complications of Balloon Pulmonary Angioplasty: A Quality Imperative.

Mahmud E, Ang L.JACC Cardiovasc Interv. 2023 Apr 24;16(8):984-985. doi: 10.1016/j.jcin.2023.02.017. Epub 2023 Mar 22.PMID: 36964098

2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee.

Writing Committee; Bass TA, Abbott JD, Mahmud E, Parikh SA, Aboulhosn J, Ashwath ML, Baranowski B, Bergersen L, Chaudry HI, Coylewright M, Denktas AE, Gupta K, Gutierrez JA, Haft J, Hawkins BM, Herrmann HC, Kapur NK, Kilic S, Lesser J, Lin CH, Mendirichaga R, Nkomo VT, Park LG, Phoubandith DR, Quader N, Rich MW, Rosenfield K, Sabri SS, Shames ML, Shernan SK, Skelding KA, Tamis-Holland J, Thourani VH, Tremmel JA, Uretsky S, Wageman J, Welt F, Whisenant BK, White CJ, Yong CM.JACC Cardiovasc Interv. 2023 Apr 20:S1936-8798(23)00707-0. doi: 10.1016/j.jcin.2023.04.011. Online ahead of print.PMID: 37115166

2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee.

Writing Committee; Bass TA, Abbott JD, Mahmud E, Parikh SA, Aboulhosn J, Ashwath ML, Baranowski B, Bergersen L, Chaudry HI, Coylewright M, Denktas AE, Gupta K, Gutierrez JA, Haft J, Hawkins BM, Herrmann HC, Kapur NK, Kilic S, Lesser J, Lin CH, Mendirichaga R, Nkomo VT, Park LG, Phoubandith DR, Quader N, Rich MW, Rosenfield K, Sabri SS, Shames ML, Shernan SK, Skelding KA, Tamis-Holland J, Thourani VH, Tremmel JA, Uretsky S, Wageman J, Welt F, Whisenant BK, White CJ, Yong CM.J Am Coll Cardiol. 2023 Apr 11;81(14):1386-1438. doi: 10.1016/j.jacc.2022.11.002. Epub 2023 Feb 16.PMID: 36801119

Blood Levels of Angiotensinogen and Hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA).

Trainor PJ, Brambatti M, Carlisle SM, Mullick AE, Shah SJ, Kahlon T, Mostacero DO, Mousavi H, Morgan ES, Tami Y, Michos ED, Ouyang P, Tsimikas S, DeFilippis AP.J Am Coll Cardiol. 2023 Apr 4;81(13):1248-1259. doi: 10.1016/j.jacc.2023.01.033.PMID: 36990544

2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee.

Bass TA, Abbott JD, Mahmud E, Parikh SA, Aboulhosn J, Ashwath ML, Baranowski B, Bergersen L, Chaudry HI, Coylewright M, Denktas AE, Gupta K, Gutierrez JA, Haft J, Hawkins BM, Herrmann HC, Kapur NK, Kilic S, Lesser J, Huie LC, Mendirichaga R, Nkomo VT, Park LG, Phoubandith DR, Quader N, Rich MW, Rosenfield K, Sabri SS, Shames ML, Shernan SK, Skelding KA, Tamis-Holland J, Thourani VH, Tremmel JA, Uretsky S, Wageman J, Welt F, Whisenant BK, White CJ, Yong CM.Circ Cardiovasc Interv. 2023 Apr;16(4):e000088. doi: 10.1161/HCV.0000000000000088. Epub 2023 Feb 16.PMID: 36795800

Impact of C-reactive protein levels on lipoprotein(a)-associated aortic stenosis incidence and progression.

Girard A, Gaillard E, Puri R, Capoulade R, Chan KL, Paulin A, Manikpurage HD, Dumesnil J, Tam JW, Teo KK, Couture C, Wareham NJ, Clavel MA, Stroes ESG, Mathieu P, Thériault S, Tsimikas S, Pibarot P, Boekholdt SM, Arsenault BJ.Eur Heart J Open. 2023 Mar 30;3(2):oead032. doi: 10.1093/ehjopen/oead032. eCollection 2023 Mar.PMID: 37077580

Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension.

Yang J, Madani MM, Mahmud E, Kim NH.Chest. 2023 Mar 28:S0012-3692(23)00457-9. doi: 10.1016/j.chest.2023.03.029. Online ahead of print.PMID: 36990148

Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial.

Witztum JL, Gaudet D, Arca M, Jones A, Soran H, Gouni-Berthold I, Stroes ESG, Alexander VJ, Jones R, Watts L, Xia S, Tsimikas S.J Clin Lipidol. 2023 Mar 22:S1933-2874(23)00065-X. doi: 10.1016/j.jacl.2023.03.007. Online ahead of print.PMID: 37100699

Left Atrial to Coronary Sinus Shunting for Treatment of Symptomatic Heart Failure.

Hibbert B, Zahr F, Simard T, Labinaz M, Nazer B, Sorajja P, Eckman P, Pineda AM, Missov E, Mahmud E, Schwartz J, Gupta B, Wiley M, Sauer A, Jorde U, Latib A, Kahwash R, Lilly S, Chang L, Gafoor S, Chaudhry SP, Hermiller J, Aldaia L, Koulogiannis K, Gray WA; ALTFLOW investigators.JACC Cardiovasc Interv. 2023 Mar 13:S1936-8798(23)00571-X. doi: 10.1016/j.jcin.2023.03.012. Online ahead of print.PMID: 36989271

Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.

Rempakos A, Simsek B, Kostantinis S, Karacsonyi J, Choi JW, Poommipanit P, Khatri JJ, Jaber W, Rinfret S, Nicholson W, Gorgulu S, Jaffer FA, Chandwaney R, Koutouzis M, Tsiafoutis I, Alaswad K, Krestyaninov O, Khelimskii D, Karmpaliotis D, Uretsky BF, Patel MP, Mahmud E, Potluri S, Rangan BV, Mastrodemos OC, Allana S, Sandoval Y, Burke NM, Brilakis ES.Catheter Cardiovasc Interv. 2023 Mar;101(4):747-755. doi: 10.1002/ccd.30581. Epub 2023 Feb 5.PMID: 36740236

Impact of proximal cap ambiguity on the procedural techniques and outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO Registry.

Kostantinis S, Simsek B, Karacsonyi J, Rempakos A, Alaswad K, Megaly M, Krestyaninov O, Khelimskii D, Karmpaliotis D, Jaffer FA, Khatri JJ, Poommipanit P, Patel MP, Mahmud E, Koutouzis M, Tsiafoutis I, Gorgulu S, Elbarouni B, Nicholson W, Jaber W, Rinfret S, Abi Rafeh N, Goktekin O, ElGuindy AM, Allana SS, Rangan BV, Sandoval Y, Burke MN, Brilakis ES.Catheter Cardiovasc Interv. 2023 Mar;101(4):737-746. doi: 10.1002/ccd.30580. Epub 2023 Feb 5.PMID: 36740235

Comparing Outcomes of Transfemoral Versus Transbrachial or Transradial Approach in Carotid Artery Stenting (CAS).

Khan MA, Dodo-Williams TS, Janssen C, Patel RJ, Mahmud E, Malas MB.Ann Vasc Surg. 2023 Feb 7:S0890-5096(23)00053-5. doi: 10.1016/j.avsg.2023.01.039. Online ahead of print.PMID: 36758939

Equipment Utilization in Chronic Total Occlusion Percutaneous Coronary Interventions: Update From the PROGRESS-CTO Registry.

Kostantinis S, Simsek B, Karacsonyi J, Rempakos A, Alaswad K, Jaffer FA, Khatri JJ, Poommipanit P, Davies RE, Rinfret S, Nicholson W, Jaber W, Choi JW, Patel MP, Koutouzis M, Tsiafoutis I, Gorgulu S, Patel TN, Jefferson BK, Kerrigan JL, Elbarouni B, Abi Rafeh N, Goktekin O, ElGuindy AM, Allana S, Mastrodemos OC, Rangan BV, Sandoval Y, Burke MN, Brilakis ES.J Invasive Cardiol. 2023 Feb;35(2):E61-E69.PMID: 36735869

69.

Intravascularly infused extracellular matrix as a biomaterial for targeting and treating inflamed tissues.

Spang MT, Middleton R, Diaz M, Hunter J, Mesfin J, Banka A, Sullivan H, Wang R, Lazerson TS, Bhatia S, Corbitt J, D'Elia G, Sandoval-Gomez G, Kandell R, Vratsanos MA, Gnanasekaran K, Kato T, Igata S, Luo C, Osborn KG, Gianneschi NC, Eniola-Adefeso O, Cabrales P, Kwon EJ, Contijoch F, Reeves RR, DeMaria AN, Christman KL.Nat Biomed Eng. 2023 Feb;7(2):94-109. doi: 10.1038/s41551-022-00964-5. Epub 2022 Dec 29.PMID: 36581694

Association of Lp(a) (Lipoprotein[a]) and Hypertension in Primary Prevention of Cardiovascular Disease: The MESA.

Rikhi R, Bhatia HS, Schaich CL, Ashburn N, Tsai MY, Michos ED, Chevli PA, Herrington DM, Tsimikas S, Shapiro MD.Hypertension. 2023 Feb;80(2):352-360. doi: 10.1161/HYPERTENSIONAHA.122.20189. Epub 2022 Dec 13.PMID: 36511156

Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation score.

Kostantinis S, Simsek B, Karacsonyi J, Alaswad K, Jaffer FA, Khatri JJ, Choi JW, Jaber WA, Rinfret S, Nicholson W, Patel MP, Mahmud E, Toma C, Davies RE, Kerrigan JL, Haddad EV, Gorgulu S, Abi-Rafeh N, ElGuindy AM, Goktekin O, Allana S, Burke MN, Mastrodemos OC, Rangan BV, Brilakis E.EuroIntervention. 2023 Jan 23;18(12):1022-1030. doi: 10.4244/EIJ-D-22-00593.PMID: 36281650

Efficacy and safety of pelacarsen in lowering Lp(a) in healthy Japanese subjects.

Karwatowska-Prokopczuk E, Lesogor A, Yan JH, Hurh E, Hoenlinger A, Margolskee A, Xia S, Tsimikas S.J Clin Lipidol. 2023 Jan-Feb;17(1):181-188. doi: 10.1016/j.jacl.2022.12.001. Epub 2022 Dec 8.PMID: 36529659 Clinical Trial.

Integrated Assessment of Phase 2 Data on GalNAc₃-Conjugated 2'-O-Methoxyethyl-Modified Antisense Oligonucleotides.

Baker BF, Xia S, Partridge W, Kwoh TJ, Tsimikas S, Bhanot S, Geary RS.Nucleic Acid Ther. 2023 Jan;33(1):72-80. doi: 10.1089/nat.2022.0044. Epub 2022 Nov 29.PMID: 36454263 Clinical Trial.

In-hospital outcomes and temporal trends of percutaneous coronary interventions for chronic total occlusion.

Kostantinis S, Simsek B, Karacsonyi J, Alaswad K, Krestyaninov O, Khelimskii D, Karmpaliotis D, Jaffer FA, Khatri JJ, Poommipanit P, Choi JW, Jaber WA, Rinfret S, Nicholson W, Patel MP, Mahmud E, Dattilo P, Gorgulu S, Koutouzis M, Tsiafoutis I, Elbarouni B, Sheikh AM, Uretsky BF, ElGuindy AM, Jefferson BK, Patel TN, Wollmuth J, Riley RF, Benton SM Jr, Davies RE, Chandwaney RH, Toma C, Yeh RW, Schimmel DR, Abi Rafeh N, Goktekin O, Kerrigan JL, Mastrodemos OC, Rangan BV, Garcia S, Sandoval Y, Burke MN, Brilakis E.EuroIntervention. 2022 Dec 2;18(11):e929-e932. doi: 10.4244/EIJ-D-22-00599.PMID: 36065983

Lipoprotein(a) and LDL-C: The Relevance of Equivalence.

Morris PB, Narula J, Tsimikas S.J Am Coll Cardiol. 2022 Nov 22;80(21):2011-2013. doi: 10.1016/j.jacc.2022.09.026.PMID: 36396202

Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study: Volanesorsen in FPLD; The BROADEN Study.

Oral EA, Garg A, Tami J, Huang EA, O'Dea LSL, Schmidt H, Tiulpakov A, Mertens A, Alexander VJ, Watts L, Hurh E, Witztum JL, Geary RS, Tsimikas S.J Clin Lipidol. 2022 Nov-Dec;16(6):833-849. doi: 10.1016/j.jacl.2022.08.008. Epub 2022 Sep 22.PMID: 36402670 Clinical Trial.

Lp(a), oxidized phospholipids and oxidation-specific epitopes are increased in subjects with keloid formation.

Ruder S, Mansfield B, Immelman AR, Varki N, Miu P, Raal F, Tsimikas S.Lipids Health Dis. 2022 Nov 1;21(1):113. doi: 10.1186/s12944-022-01720-z.PMID: 36320028

Incidence, Mechanisms, Treatment, and Outcomes of Coronary Artery Perforation During Chronic Total Occlusion Percutaneous Coronary Intervention.

Kostantinis S, Simsek B, Karacsonyi J, Alaswad K, Krestyaninov O, Khelimskii D, Karmpaliotis D, Jaffer FA, Khatri JJ, Poommipanit P, Jaber WA, Rinfret S, Nicholson W, Patel MP, Mahmud E, Koutouzis M, Tsiafoutis I, Benton SM Jr, Davies RE, Toma C, Kerrigan JL, Haddad EV, Abi-Rafeh N, ElGuindy AM, Goktekin O, Mastrodemos OC, Rangan BV, Burke MN, Brilakis ES.Am J Cardiol. 2022 Nov 1;182:17-24. doi: 10.1016/j.amjcard.2022.07.004. Epub 2022 Aug 24.PMID: 36028387

Association of heart failure with procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with atrial fibrillation: insights from the national inpatient sample of 62 980 procedures.

Munir MB, Khan MZ, Darden D, Abideen Asad ZU, Osman M, Singh GD, Srivatsa UN, Han FT, Reeves R, Hsu JC.Europace. 2022 Oct 13;24(9):1451-1459. doi: 10.1093/europace/euac043.PMID: 35613020

Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes.

Lacaze P, Bakshi A, Riaz M, Polekhina G, Owen A, Bhatia HS, Natarajan P, Wolfe R, Beilin L, Nicholls SJ, Watts GF, McNeil JJ, Tonkin AM, Tsimikas S.J Am Coll Cardiol. 2022 Oct 4;80(14):1287-1298. doi: 10.1016/j.jacc.2022.07.027.PMID: 36175048 Clinical Trial.

Patient selection for balloon pulmonary angioplasty: Six-year results from a high volume PTE surgical center.

Poch DS, Mahmud E, Patel M, Papamatheakis D, Fernandes T, Kerr K, Yang J, Pretorius V, Madani MM, Kim NH.Pulm Circ. 2022 Oct 1;12(4):e12148. doi: 10.1002/pul2.12148. eCollection 2022 Oct.PMID: 36325508

Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease.

Nissen SE, Wolski K, Cho L, Nicholls SJ, Kastelein J, Leitersdorf E, Landmesser U, Blaha M, Lincoff AM, Morishita R, Tsimikas S, Liu J, Manning B, Kozlovski P, Lesogor A, Thuren T, Shibasaki T, Matei F, Silveira FS, Meunch A, Bada A, Vijan V, Bruun NE, Nordestgaard BG; Lp(a)HERITAGE Investigators.Open Heart. 2022 Oct;9(2):e002060. doi: 10.1136/openhrt-2022-002060.PMID: 36252994

Intravascular lithotripsy in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.

Kostantinis S, Simsek B, Karacsonyi J, Davies RE, Benton S, Nicholson W, Rinfret S, Jaber WA, Raj L, Sandesara PB, Alaswad K, Basir MB, Megaly M, Khatri JJ, Young LD, Jaffer FA, Abi Rafeh N, Patel MP, Kerrigan JL, Haddad EV, Dattilo P, Sandoval Y, Schimmel DR, Sheikh AM, ElGuindy AM, Goktekin O, Mastrodemos OC, Rangan BV, Burke MN, Brilakis ES.Catheter Cardiovasc Interv. 2022 Oct;100(4):512-519. doi: 10.1002/ccd.30354. Epub 2022 Aug 2.PMID: 35916076

Association of advanced age with procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with atrial fibrillation: insights from the National Inpatient Sample of 36,065 procedures.

Munir MB, Khan MZ, Darden D, Asad ZUA, Choubdar PA, Din MTU, Osman M, Singh GD, Srivatsa UN, Balla S, Reeves R, Hsu JC.J Interv Card Electrophysiol. 2022 Oct;65(1):219-226. doi: 10.1007/s10840-022-01266-1. Epub 2022 Jun 22.PMID: 35731328

Coronary morphological features in women with non-ST-segment elevation MINOCA and MI-CAD as assessed by optical coherence tomography.

Usui E, Matsumura M, Smilowitz NR, Mintz GS, Saw J, Kwong RY, Hada M, Mahmud E, Giesler C, Shah B, Bangalore S, Razzouk L, Hoshino M, Marzo K, Ali ZA, Bairey Merz CN, Sugiyama T, Har B, Kakuta T, Hochman JS, Reynolds HR, Maehara A.Eur Heart J Open. 2022 Sep 30;2(5):oeac058. doi: 10.1093/ehjopen/oeac058. eCollection 2022 Sep.PMID: 36225342

Effect of olezarsen targeting APOC-III on lipoprotein size and particle number measured by NMR in patients with hypertriglyceridemia.

Karwatowska-Prokopczuk E, Tardif JC, Gaudet D, Ballantyne CM, Shapiro MD, Moriarty PM, Baum SJ, Amour ES, Alexander VJ, Xia S, Otvos JD, Witztum JL, Tsimikas S; Olezarsen Trial Investigators.J Clin Lipidol. 2022 Sep-Oct;16(5):617-625. doi: 10.1016/j.jacl.2022.06.005. Epub 2022 Jun 23.PMID: 35902351

Ancestry, Lipoprotein(a), and Cardiovascular Risk Thresholds: JACC Review Topic of the Week.

Tsimikas S, Marcovina SM.J Am Coll Cardiol. 2022 Aug 30;80(9):934-946. doi: 10.1016/j.jacc.2022.06.019.PMID: 36007992

Prognosis is worse with elevated cardiac troponin in nonacute coronary syndrome compared with acute coronary syndrome.

Horiuchi Y, Wettersten N, Patel MP, Mueller C, Neath SX, Christenson RH, Morgenthaler NG, McCord J, Nowak RM, Vilke GM, Daniels LB, Hollander JE, Apple FS, Cannon CM, Nagurney JT, Schreiber D, deFilippi C, Hogan C, Diercks DB, Headden G, Limkakeng AT Jr, Anand I, Wu AHB, Ebmeyer S, Jaffe AS, Peacock WF, Maisel A.Coron Artery Dis. 2022 Aug 1;33(5):376-384. doi: 10.1097/MCA.0000000000001135. Epub 2022 Mar 8.PMID: 35880560

Oxidized phospholipids on apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS study.

Clarke R, Hammami I, Sherliker P, Valdes-Marquez E, Watkins H, Hill M, Yang X, Tsimikas S, Hopewell JC; PROCARDIS Consortium.Atherosclerosis. 2022 Aug;354:15-22. doi: 10.1016/j.atherosclerosis.2022.06.1020. Epub 2022 Jun 25.PMID: 35803063

Development and validation of an isoform-independent monoclonal antibody-based ELISA for measurement of lipoprotein(a).

Marcovina SM, Navabi N, Allen S, Gonen A, Witztum JL, Tsimikas S.J Lipid Res. 2022 Aug;63(8):100239. doi: 10.1016/j.jlr.2022.100239. Epub 2022 Jun 8.PMID: 35688187

Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride lowering.

Ramms B, Patel S, Sun X, Pessentheiner AR, Ducasa GM, Mullick AE, Lee RG, Crooke RM, Tsimikas S, Witztum JL, Gordts PL.JCI Insight. 2022 Jul 8;7(13):e158414. doi: 10.1172/jci.insight.158414.PMID: 35653195

Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19.

Garcia S, Dehghani P, Stanberry L, Grines C, Patel RAG, Nayak KR, Singh A, Htun WW, Kabour A, Ghasemzadeh N, Sanina C, Aragon J, Alraies MC, Benziger C, Okeson B, Garberich R, Welt FG, Davidson L, Hafiz AM, Acharya D, Stone J, Mehra A, Amlani S, Mahmud E, Giri J, Yildiz M, Henry TD.J Am Coll Cardiol. 2022 Jun 7;79(22):2236-2244. doi: 10.1016/j.jacc.2022.03.345. Epub 2022 Apr 4.PMID: 35390486

Right Ventricular and Pulmonary Computed Tomography Assessments in Paradoxical Low-Flow Low-Gradient Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.

Rigolli M, Reeves R, Smitson C, Yang J, Alotaibi M, Mahmud E, Malhotra A, Contijoch F.Struct Heart. 2022 Jun;6(2):100014. doi: 10.1016/j.shj.2022.100014. Epub 2022 Mar 30.PMID: 36212028

Monitoring peripheral hemodynamic response to changes in blood pressure via photoacoustic imaging.

Mantri Y, Dorobek TR, Tsujimoto J, Penny WF, Garimella PS, Jokerst JV.Photoacoustics. 2022 Mar 9;26:100345. doi: 10.1016/j.pacs.2022.100345. eCollection 2022 Jun.PMID: 35295617

Trends in testing and prevalence of elevated Lp(a) among patients with aortic valve stenosis.

Bhatia HS, Ma GS, Taleb A, Wilkinson M, Kahn AM, Cotter B, Yeang C, DeMaria AN, Patel MP, Mahmud E, Reeves RR, Tsimikas S.Atherosclerosis. 2022 May;349:144-150. doi: 10.1016/j.atherosclerosis.2022.01.022. Epub 2022 Jan 31.PMID: 35144769

Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk.

Tardif JC, Karwatowska-Prokopczuk E, Amour ES, Ballantyne CM, Shapiro MD, Moriarty PM, Baum SJ, Hurh E, Bartlett VJ, Kingsbury J, Figueroa AL, Alexander VJ, Tami J, Witztum JL, Geary RS, O'Dea LSL, Tsimikas S, Gaudet D.Eur Heart J. 2022 Apr 6;43(14):1401-1412. doi: 10.1093/eurheartj/ehab820.PMID: 35025993 Clinical Trial.

Generation of cardio-protective antibodies after pneumococcal polysaccharide vaccine: Early results from a randomised controlled trial.

Ren S, Hansbro PM, Srikusalanukul W, Horvat JC, Hunter T, Brown AC, Peel R, Faulkner J, Evans TJ, Li SC, Newby D, Hure A, Abhayaratna WP, Tsimikas S, Gonen A, Witztum JL, Attia J; AUSPICE investigators.Atherosclerosis. 2022 Apr;346:68-74. doi: 10.1016/j.atherosclerosis.2022.02.011. Epub 2022 Mar 5.PMID: 35290813 Clinical Trial.

Selective Valve Removal for Melody Valve Endocarditis: Practice Variations in a Multicenter Experience.

Davtyan A, Guyon PW, El-Sabrout HR, Ponder R, Ramchandar N, Weber R, Zayed W, Ratnayaka K, Nigro JJ, Moore JW, Bauser-Heaton H, Alshawabkeh L, Reeves RR, Levi D, Aboulhosn J, Justino H, Bradley J, El-Said HG.Pediatr Cardiol. 2022 Apr;43(4):894-902. doi: 10.1007/s00246-021-02801-z. Epub 2021 Dec 11.PMID: 34894280

Effect of Pelacarsen on Lipoprotein(a) Cholesterol and Corrected Low-Density Lipoprotein Cholesterol.

Yeang C, Karwatowska-Prokopczuk E, Su F, Dinh B, Xia S, Witztum JL, Tsimikas S.J Am Coll Cardiol. 2022 Mar 22;79(11):1035-1046. doi: 10.1016/j.jacc.2021.12.032.PMID: 35300814 Clinical Trial.

Atherothrombotic factors and atherosclerotic cardiovascular events: the multi-ethnic study of atherosclerosis.

DeFilippis AP, Trainor PJ, Thanassoulis G, Brumback LC, Post WS, Tsai MY, Tsimikas S.Eur Heart J. 2022 Mar 7;43(10):971-981. doi: 10.1093/eurheartj/ehab600.PMID: 34508626

Lipoprotein(a) and Coronary Calcium: Clinical Management and Potential Design of Primary Prevention Trials.

Tsimikas S.J Am Coll Cardiol. 2022 Mar 1;79(8):769-771. doi: 10.1016/j.jacc.2021.12.018.PMID: 35210031

Photoacoustic monitoring of angiogenesis predicts response to therapy in healing wounds.

Mantri Y, Tsujimoto J, Donovan B, Fernandes CC, Garimella PS, Penny WF, Anderson CA, Jokerst JV.Wound Repair Regen. 2022 Mar;30(2):258-267. doi: 10.1111/wrr.12992. Epub 2022 Jan 12.PMID: 34985822

A Charge-Switchable Zwitterionic Peptide for Rapid Detection of SARS-CoV-2 Main Protease.

Jin Z, Mantri Y, Retout M, Cheng Y, Zhou J, Jorns A, Fajtova P, Yim W, Moore C, Xu M, Creyer MN, Borum RM, Zhou J, Wu Z, He T, Penny WF, O'Donoghue AJ, Jokerst JV.Angew Chem Int Ed Engl. 2022 Feb 21;61(9):e202112995. doi: 10.1002/anie.202112995. Epub 2022 Jan 14.PMID: 34936725

Lipoprotein(a) and CT Angiography: Novel Insights Into High-Risk Plaque Progression.

Tsimikas S, Narula J.J Am Coll Cardiol. 2022 Jan 25;79(3):234-237. doi: 10.1016/j.jacc.2021.11.015.PMID: 35057908

A fiber optic photoacoustic sensor for real-time heparin monitoring.

Zhou J, Yim W, Zhou J, Jin Z, Xu M, Mantri Y, He T, Cheng Y, Fu L, Wu Z, Hancock T, Penny W, Jokerst JV.Biosens Bioelectron. 2022 Jan 15;196:113692. doi: 10.1016/j.bios.2021.113692. Epub 2021 Oct 6.PMID: 34653712

Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study.

Nurmohamed NS, Collard D, Reeskamp LF, Kaiser Y, Kroon J, Tromp TR; Amsterdam UMC Covid-19 Biobank; van den Born BH, Coppens M, Vlaar APJ, Beudel M, van de Beek D, van Es N, Moriarty PM, Tsimikas S, Stroes ESG.Atherosclerosis. 2022 Jan;341:43-49. doi: 10.1016/j.atherosclerosis.2021.12.008. Epub 2021 Dec 21.PMID: 34995986

Use of the Ocelot catheter in iliac chronic total occlusion intervention.

Walters D, Al Khiami B, Mahmud E, Patel M.Cardiovasc Revasc Med. 2018 Oct;19(7 Pt A):795-798. doi: 10.1016/j.carrev.2018.02.006. Epub 2018 Feb 13.PMID: 29550048

Widespread Down-Regulation of Cardiac Mitochondrial and Sarcomeric Genes in Patients With Sepsis.

Matkovich SJ, Al Khiami B, Efimov IR, Evans S, Vader J, Jain A, Brownstein BH, Hotchkiss RS, Mann DL.Crit Care Med. 2017 Mar;45(3):407-414. doi: 10.1097/CCM.0000000000002207.PMID: 28067713